ANN ARBOR - A multi-center trial led by the University of Michigan Health System finds short-term replacement of renal cell function with the bioartificial kidney speeds recovery and reduces a patient's mortality risk by 50 percent. The study - published in the Journal of the American Society of Nephrology - is one in a string
ALLEGAN - The Perrigo Company announced Thursday that it has received approval from the U.S. Food and Drug Administration to market an over-the-counter version of Nicorette gum, which is an aid to smoking cessation. The overall market for OTC nicotine gum and lozenge products is estimated at approximately $750 million annually at all retail outlets.
ANN ARBOR ? MichBio Executive Director Stephen Rapundalo said Michigan has created a buzz out there ? the Upper Hand ads in tandem with the state-supported 21st Century Jobs Fund, are generating a lot of interest among the nation's biotech community. Rapundalo, in his remarks during the MichBio annual meeting Tuesday night in Ann Arbor,
ANN ARBOR ? MichBio, the state's life sciences trade association, will be hosting a workshop on April 22 to look at how biotechnology companies can select the best funding sources. The workshop is scheduled in the afternoon just before the MichBio annual meeting. The workshop is called Capital Formation: Lost in Translation. Industry experts will
DEARBORN - Wayne State University School of Medicine and Oakwood Healthcare System surgeons successfully implanted a new device designed to combat congestive heart failure in a 49-year-old patient that has ushered in a new tool to combat a condition that kills 300,000 Americans annually. The April 1 surgery took place at Oakwood Hospital & Medical
LANSING - Moving closer to action on a series of bills that would revise Michigan's individual health insurance market - as well as allow Blue Cross/Blue Shield of Michigan to acquire other companies - Senate substitutes for the bills are expected to be unveiled this week. No voting is expected this week on the versions
ANN ARBOR - NanoBio Corporation reported top-level findings Monday from its phase 2b study of NB-001, a topical lotion to treat herpes labialis (cold sores). The randomized, double-blind, vehicle- controlled study met its primary and secondary endpoints by demonstrating clear efficacy and safety in 482 patients. NanoBio's lotion resulted in faster healing of cold sores,
CLEVELAND ? A new study by an Ohio bioscience development organization shows Illinois is the top state in the Midwest in medical device companies, with Ohio second and Michigan ranked fourth. Using FDA registration records, BioEnterprise reported 966 companies in Illinois have registered with the FDA for medical devices. Registered medical device companies include both
ROCHESTER ? Michigan Senator Carl Levin will be a guest speaker at Oakland University's Midwest Conference on Stem Cell Biology and Therapy May 9?11 at Meadow Brook Hall. The conference also will bring together scientists and clinicians from across the globe to share the latest advancements in stem cell research. The conference will address the
ALLEGAN - Perrigo Company reported Monday it has received final approval from the U.S. Food and Drug Administration to manufacture a generic brand of Olux Foam, a topical corticosteroid for treatment of dermatosis of the scalp. Before that happens, however, Perrigo must await a decision later this month on a patent infringement lawsuit filed in